Lv1
38 积分 2026-03-07 加入
Updated results from inMMyCAR, the ongoing first-in-human phase 1 study of KLN-1010 in patients (pts) with relapsed and refractory multiple myeloma (RRMM)
7小时前
求助中
The landscape for in vivo CAR T cell therapies
7小时前
已完结
Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma
8小时前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
8个月前
已完结
皖公网安备34019202002308
